Hysingla ER 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F1U64
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,104
Award facts
- Contract value 100% obligated
- $3,104.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,104.21 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Hysingla ER 30 mg tablets (60-count). This is a firm fixed-price, non-set-aside contract with performance completion scheduled for January 14, 2026, and the pharmaceutical products will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and established federal vendor specializing in medical procurement for military and veteran healthcare systems. The company demonstrates significant federal contracting capability through its extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency, covering diverse therapeutic domains including pain management, neurological treatments, and specialty medications. All of the company's reviewed contract awards have been competitively awarded without set-asides, reflecting its capacity to meet federal procurement standards through open competition and supporting critical medical supply needs for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1U64?
SPE2DR26F1U64 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1U64 worth?
The government has obligated $3,104 on SPE2DR26F1U64.
Is contract SPE2DR26F1U64 an order under another contract?
Yes. SPE2DR26F1U64 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U64 competed?
The extent of competition for SPE2DR26F1U64 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award